Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
about
Identification of miRNA-mRNA Modules in Colorectal Cancer Using Rough Hypercuboid Based Supervised ClusteringMeta-signature LncRNAs serve as novel biomarkers for colorectal cancer: integrated bioinformatics analysis, experimental validation and diagnostic evaluationCirculating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular CarcinomaMiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells.miR-224-3p inhibits autophagy in cervical cancer cells by targeting FIP200Methylation-regulated miR-124-1 suppresses tumorigenesis in hepatocellular carcinoma by targeting CASC3.A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosisHigh expression of miR-105-1 positively correlates with clinical prognosis of hepatocellular carcinoma by targeting oncogene NCOA1.Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer.Integrated analysis of the potential roles of miRNA‑mRNA networks in triple negative breast cancer.Clinical value of integrated-signature miRNAs in esophageal cancer.miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature.Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinoma.Circulating microRNAs for early detection of hepatitis B-related hepatocellular carcinoma.Identification of microRNAs as potential biomarkers for lung adenocarcinoma using integrating genomics analysis.Prediction of clinical outcome and survival in soft-tissue sarcoma using a ten-lncRNA signature.Reduced miR-125a levels associated with poor survival of patients with hepatocellular cancer.MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis.Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis.MicroRNA deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis.Diagnosis, prognosis and bioinformatics analysis of lncRNAs in hepatocellular carcinoma.MiR-93-5p Promotes Cell Proliferation through Down-Regulating PPARGC1A in Hepatocellular Carcinoma Cells by Bioinformatics Analysis and Experimental Verification.Profound changes in miRNA expression during cancer initiation by aflatoxin B1 and their abrogation by the chemopreventive triterpenoid CDDO-Im.Genetic variant in DICER gene is associated with prognosis of hepatocellular carcinoma in a Chinese cohort.Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis.Identification of four plasma microRNAs as potential biomarkers in the diagnosis of male lung squamous cell carcinoma patients in China.A Comprehensive Analysis of Argonaute-CLIP Data Identifies Novel, Conserved and Species-Specific Targets of miR-21 in Human Liver and Hepatocellular Carcinoma.The down-regulation of the CYP2C19 gene is associated with aggressive tumor potential and the poorer recurrence-free survival of hepatocellular carcinoma.
P2860
Q29248741-25000852-94E7-4F09-894A-EABC7E660333Q33559988-2F999D94-63A3-4B23-89B9-01E14FFA7DE0Q33687038-E155C6D0-A1DB-4DE5-AC8F-27DA78AD3EB0Q33911829-C72F5857-1513-4B2B-8BB8-2FF15FFE4850Q36508613-2E363D88-B486-406E-9DEF-FB48F591A814Q37248128-0BC9B4C2-BC89-4A2E-BC2C-1A228A534937Q37295572-11342E07-D417-402B-AAAD-8132F629BBC0Q37702806-E19A8EAC-64F4-46A2-BA67-2BB050B3B3D0Q37707012-578BCB84-AEE6-4542-A7D8-B03785E0E136Q37728657-C0ED8114-9F22-4E6E-8769-9761DA20420BQ38432304-94F60DCC-8CD9-4840-BAB4-CB2CC06304ACQ38679534-98EBA8C3-5D4C-4FAA-9591-9A6F05A7B190Q38714556-DBC0CA96-9715-4DB1-90FA-EF3BBC3581F9Q38732775-1F83C2CD-2D30-463E-81A3-B5DE63781A86Q41822877-15DDF574-7A8B-4FFD-8B1C-C970E7EC13E2Q42119857-09AAA572-6978-43DF-840B-277D32B83114Q43166037-FF045472-9134-4804-A3E3-C1280CFCA35FQ45782957-5A78AF1C-E67D-4DEE-9031-F3C149162FE4Q46258926-9BCA3009-0493-4F6C-833C-AA9B4151775BQ47096853-008DB644-00E9-4356-A08B-D4B1D9901EFFQ47142430-FD36FE9B-1785-4C31-9339-338C77E1B468Q47160779-B26E8359-2354-40F0-A87A-A2E409D452FEQ47716490-0DB47C69-6729-4447-B533-E4AB13C794C2Q48218461-4CA4A3CB-00AF-4BD9-9CE2-BCAC3598FAF7Q51793684-2C7294BC-175A-4478-AB51-CC462F41B575Q52316494-D36C0564-5330-43C5-B149-D4923101C314Q52577567-9CB702F1-2AA7-407F-8F83-B263A5225E27Q52656068-2ECA6B0B-D7A0-48A9-8AF8-7BC39000D6DFQ55324715-E3F1C79A-D1F6-4A51-A54B-E9357DC6B019
P2860
Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Hepatocellular carcinoma assoc ...... ion and clinical significance.
@ast
Hepatocellular carcinoma assoc ...... ion and clinical significance.
@en
type
label
Hepatocellular carcinoma assoc ...... ion and clinical significance.
@ast
Hepatocellular carcinoma assoc ...... ion and clinical significance.
@en
prefLabel
Hepatocellular carcinoma assoc ...... ion and clinical significance.
@ast
Hepatocellular carcinoma assoc ...... ion and clinical significance.
@en
P2093
P2860
P356
P1433
P1476
Hepatocellular carcinoma assoc ...... tion and clinical significance
@en
P2093
Jin-Zhong Dong
Nai-Bing Yang
Xiang-Jian Chen
Yi-Jing Cai
Yong-Ping Chen
Yu-Qun Wang
P2860
P304
25093-25108
P356
10.18632/ONCOTARGET.4437
P407
P577
2015-09-01T00:00:00Z